GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
6.56
+1.34 (25.67%)
At close: Jun 27, 2025, 4:00 PM
6.15
-0.41 (-6.25%)
After-hours: Jun 27, 2025, 7:59 PM EDT
GlucoTrack Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
3.13M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
GCTK News
- 2 days ago - Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday? - Benzinga
- 2 days ago - Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions - GlobeNewsWire
- 15 days ago - Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements - GlobeNewsWire
- 23 days ago - Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions - GlobeNewsWire
- 4 weeks ago - Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD - GlobeNewsWire
- 5 weeks ago - Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development - GlobeNewsWire
- 6 weeks ago - Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 6 weeks ago - Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor - GlobeNewsWire